RxDoctor Payments DataLook up a doctor →

Julia Garcia-Diaz

Infectious Disease · New Orleans, LANPI 1700844594

Payments from drug & device makers

$9,863,320in general payments, 2019–2025

Across 720 payments — averaging $13,699 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$5.5M
  • Janssen Research & Development, LLC$2M
  • Hoffmann-la Roche Limited$798K
  • Merck$773K
  • Roche Products Limited$301K
  • Genentech, Inc.$283K
  • plus $180K from 11 others
$4,591in research payments, 2019–2025

Across 10 payments — averaging $459.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$2K
  • Astellas Pharma Global Development$2K

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,863,320 in reported general payments places this provider in the 95th percentile of 105 infectious disease providers in Louisiana.

See all infectious disease providers in Louisiana

Other infectious disease in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →